Cupps Capital Management’s Abiomed Inc ABMD Stock Holding History

Cupps Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$7.78M	Sell	60,492 -76,161	-56%	-$9.12M	3.37%	2
2016 Q2	$14.9M	Sell	136,653 -62,931	-32%	-$6.26M	3.86%	1
2016 Q1	$18.9M	Sell	199,584 -78,177	-28%	-$6.6M	3.61%	1
2015 Q4	$25.1M	Sell	277,761 -71,315	-20%	-$6.05M	3.51%	1
2015 Q3	$32.4M	Sell	349,076 -78,457	-18%	-$6.91M	4.3%	1
2015 Q2	$28.1M	Buy	427,533 +159,009	+59%	+$10.6M	2.7%	4
2015 Q1	$19.2M	Buy	268,524 +96,140	+56%	+$5.22M	1.71%	8
2014 Q4	$6.56M	Buy	172,384 +115,209	+202%	+$3.63M	0.59%	59
2014 Q3	$1.42M	Buy	+57,175	New	+$1.45M	0.13%	131
2014 Q2	–	Sell	-175,994	Closed	-$4.58M	–	247
2014 Q1	$4.58M	Sell	175,994 -75,641	-30%	-$2.09M	0.35%	94
2013 Q4	$6.73M	Buy	+251,635	New	+$6.22M	0.46%	75

Other funds holding ABMD

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Cupps Capital Management's ABMD Position: Q3 2016 in Review

Cupps Capital Management reduced its Abiomed Inc (ABMD) stake by 56% in Q3 2016, selling an estimated $9.12M and leaving 60,492 shares worth $7.78M. The position accounts for 3.37% of the portfolio, ranked #2.

Cupps Capital Management first reported a position in ABMD in Q4 2013 and has held it in 11 quarters since. The position peaked at $32.4M in Q3 2015. 306 funds tracked by Wall St. Rank hold ABMD as of Q3 2016.

Cupps Capital Management held 60,492 shares of Abiomed Inc worth $7.78M as of Q3 2016.
Cupps Capital Management sold 76,161 Abiomed Inc shares in Q3 2016, an estimated $9.12M.
Abiomed Inc made up 3.37% of Cupps Capital Management's portfolio in Q3 2016, its #2 holding.
Cupps Capital Management first reported a position in Abiomed Inc in Q4 2013 and has held it in 11 quarters since.
Cupps Capital Management's Abiomed Inc position peaked at $32.4M in Q3 2015.
306 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.